Ziegler JL - Search Results

1

Lack of germ-line promoter methylation in BRCA1-negative families with familial breast cancer.

Chen Y, Toland AE, McLennan J, Fridlyand J, Crawford B, Costello JF, Ziegler JL. Chen Y, et al. Among authors: ziegler jl. Genet Test. 2006 Winter;10(4):281-4. doi: 10.1089/gte.2006.10.281. Genet Test. 2006. PMID: 17253935

2

Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital.

Lee R, Beattie M, Crawford B, Mak J, Stewart N, Komaromy M, Esserman L, Shaw L, McLennan J, Strachowski L, Luce J, Ziegler J. Lee R, et al. Genet Test. 2005 Winter;9(4):306-12. doi: 10.1089/gte.2005.9.306. Genet Test. 2005. PMID: 16379544

3

Development and pilot evaluation of novel genetic educational materials designed for an underserved patient population.

Lubitz RJ, Komaromy M, Crawford B, Beattie M, Lee R, Luce J, Ziegler J. Lubitz RJ, et al. Genet Test. 2007 Fall;11(3):276-90. doi: 10.1089/gte.2007.0012. Genet Test. 2007. PMID: 17949289

4

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.

Kim DH, Crawford B, Ziegler J, Beattie MS. Kim DH, et al. Fam Cancer. 2009;8(2):153-8. doi: 10.1007/s10689-008-9220-x. Epub 2008 Oct 15. Fam Cancer. 2009. PMID: 18855126 Free PMC article.

5

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers.

Beattie MS, Crawford B, Lin F, Vittinghoff E, Ziegler J. Beattie MS, et al. Genet Test Mol Biomarkers. 2009 Feb;13(1):51-6. doi: 10.1089/gtmb.2008.0067. Genet Test Mol Biomarkers. 2009. PMID: 19309274 Free PMC article.

6

Ductal carcinoma in situ in BRCA mutation carriers.

Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL. Hwang ES, et al. Among authors: ziegler jl. J Clin Oncol. 2007 Feb 20;25(6):642-7. doi: 10.1200/JCO.2005.04.0345. Epub 2007 Jan 8. J Clin Oncol. 2007. PMID: 17210933

7

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

Powell CB, Kenley E, Chen LM, Crawford B, McLennan J, Zaloudek C, Komaromy M, Beattie M, Ziegler J. Powell CB, et al. J Clin Oncol. 2005 Jan 1;23(1):127-32. doi: 10.1200/JCO.2005.04.109. J Clin Oncol. 2005. PMID: 15625367

8

Breast tumor copy number aberration phenotypes and genomic instability.

Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R, Dairkee S, Tokuyasu T, Ljung BM, Jain AN, McLennan J, Ziegler J, Chin K, Devries S, Feiler H, Gray JW, Waldman F, Pinkel D, Albertson DG. Fridlyand J, et al. BMC Cancer. 2006 Apr 18;6:96. doi: 10.1186/1471-2407-6-96. BMC Cancer. 2006. PMID: 16620391 Free PMC article.

9

Risk-reducing salpingo-oophorectomy (RRSO) in BRCA mutation carriers: experience with a consecutive series of 111 patients using a standardized surgical-pathological protocol.

Powell CB, Chen LM, McLennan J, Crawford B, Zaloudek C, Rabban JT, Moore DH, Ziegler J. Powell CB, et al. Int J Gynecol Cancer. 2011 Jul;21(5):846-51. doi: 10.1097/IGC.0b013e31821bc7e3. Int J Gynecol Cancer. 2011. PMID: 21670699

10

Infectious agents and human malignancies.

Ziegler JL, Buonaguro FM. Ziegler JL, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(9):3455-64. doi: 10.2741/3464. Front Biosci (Landmark Ed). 2009. PMID: 19273286 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters